Naoyasu Umeda
- Molecular Biology
- Ophthalmology top 2%
- Radiology, Nuclear Medicine and Imaging top 10%
- Immunology and Allergy top 10%
- Cellular and Molecular Neuroscience
- Co-authors
- Shu KachiPeter A. CampochiaroHideo AkiyamaHiroaki OzakiKenji OshimaYuji OshimaHiroyuki NambuHideyuki Hayashi
- Topics
- Retinal Diseases and Treatments (11 papers)Angiogenesis and VEGF in Cancer (5 papers)Retinal and Macular Surgery (5 papers)
- Partner nations
- United StatesJapan
In The Last Decade
Naoyasu Umeda
15 papers receiving 433 citations
Peers
Comparison fields: 5 of 53
- Molecular Biology 264
- Ophthalmology 254
- Radiology, Nuclear Medicine and Imaging 173
- Immunology and Allergy 44
- Cellular and Molecular Neuroscience 35
Countries citing papers authored by Naoyasu Umeda
This map shows the geographic impact of Naoyasu Umeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoyasu Umeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoyasu Umeda more than expected).
Fields of papers citing papers by Naoyasu Umeda
This network shows the impact of papers produced by Naoyasu Umeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoyasu Umeda. The network helps show where Naoyasu Umeda may publish in the future.
Co-authorship network of co-authors of Naoyasu Umeda
This figure shows the co-authorship network connecting the top 25 collaborators of Naoyasu Umeda. A scholar is included among the top collaborators of Naoyasu Umeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoyasu Umeda. Naoyasu Umeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 1 | |
| 3 | Clinical outcomes and prognostic factors associated with Acanthamoeba keratitis treated with pentamidine isethionate | 1 |
| 4 | 37 | |
| 5 | 53 | |
| 6 | 4 | |
| 7 | 60 | |
| 8 | 52 | |
| 9 | Suppression and Regression of Choroidal Neovascularization by Systemic Administration of an 5ß1 Integrin Antagonist | 2 |
| 10 | 22 | |
| 11 | 42 | |
| 12 | 88 | |
| 13 | 27 | |
| 14 | 34 | |
| 15 | 19 | |
| 16 | Modulations in the expression of PEDF in avascular and vascular proliferative periretinal membranes in PVR, PDR and ROP | 1 |
About Naoyasu Umeda
Naoyasu Umeda is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Endocrinology, having authored 16 papers that have together received 450 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (11 papers), Angiogenesis and VEGF in Cancer (5 papers) and Retinal and Macular Surgery (5 papers). The work is most often cited by research in Ophthalmology (254 citations), Radiology, Nuclear Medicine and Imaging (173 citations) and Immunology and Allergy (44 citations). Naoyasu Umeda has collaborated with scholars based in United States and Japan. Frequent co-authors include Shu Kachi, Peter A. Campochiaro, Hideo Akiyama, Hiroaki Ozaki, Kenji Oshima, Yuji Oshima, Hiroyuki Nambu, Hideyuki Hayashi, Roland Stragies and Grit Zahn. Their work appears in journals such as The FASEB Journal, Molecular Pharmacology and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.